Related content

Determination of Caffeine and its Metabolites in Saliva and Urine as a Measure of CYP1A2 Metabolic Activity

By  

Current Pharmaceutical Analysis, Vol. 12, Iss. 4, 2016-09 ,pp. : 325-332

Bentham Science Publishers

Access to resources Recommend Favorite

Caffeine Metabolic Ratios for the In Vivo Evaluation of CYP1A2, N-acetyltransferase 2, Xanthine Oxidase and CYP2A6 Enzymatic Activities

By  

Current Drug Metabolism, Vol. 10, Iss. 4, 2009-05 ,pp. : 329-338

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma Metabolic Profiling of Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography/Mass Spectrometry

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 14, Iss. 2, 2014-09 ,pp. : 113-120

Bentham Science Publishers

Access to resources Recommend Favorite

Comparing the Relative Oxidative DNA Damage Caused by Various Arsenic Species by Quantifying Urinary Levels of 8-Hydroxy-2′-Deoxyguanosine with Isotope-Dilution Liquid Chromatography/Mass Spectrometry

By Wu Jin-Zhu   Ho Paul  

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1525-1533

Springer Publishing Company

Access to resources Recommend Favorite

Liquid Chromatography-Mass Spectrometry Method for the Determination of Olanzapine in Human Plasma and Application to a Bioequivalence Study

By  

Current Pharmaceutical Analysis, Vol. 8, Iss. 3, 2012-09 ,pp. : 247-254

Bentham Science Publishers

Access to resources Recommend Favorite